Product Information
LIDOCAINE HCL 1% 300 MG/30 ML is a generic product labeled by Eugia US LLC, priced at $0.0681 per ML under NDC 55150016300. Its NADAC has been published 50 times since Oct 22, 2025.
FDA first approved this application on Mar 14, 2013. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Eugia US LLCNDC
55150016300
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203082FDA Approved
3/14/2013
TE Code
AP
On Market Since
3/14/2013
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 1% 300 MG/30 ML has been published 50 times since Oct 22, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0681 per ML |
|---|---|
| All-time high | $0.0718 (Jun 10, 2026) |
| All-time low | $0.0667 (Feb 18, 2026) |
| 52-week high | $0.0718 |
| 52-week low | $0.0667 |
| Median price | $0.0680 |
| Average price | $0.0687 |
| Largest weekly change | +4.1% (May 20, 2026) |
| Weeks tracked | 50 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 1% 300 MG/30 ML?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 1% 300 MG/30 ML, manufactured by Eugia US LLC, is $0.0681 per ML (NDC 55150016300), effective Sep 30, 2026.
How has the price of LIDOCAINE HCL 1% 300 MG/30 ML changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 1% 300 MG/30 ML has held within roughly two percent of its current level. It has been tracked across 50 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 1% 300 MG/30 ML?
Since Oct 22, 2025, the NADAC for LIDOCAINE HCL 1% 300 MG/30 ML has ranged from a low of $0.0667 (Feb 18, 2026) to a high of $0.0718 (Jun 10, 2026), with a median of $0.0680 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 1% 300 MG/30 ML?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LIDOCAINE HCL 1% 300 MG/30 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures LIDOCAINE HCL 1% 300 MG/30 ML?
LIDOCAINE HCL 1% 300 MG/30 ML (NDC 55150016300) is labeled by Eugia US LLC, and CMS classifies it as a generic product.